Vor Biopharma Inc (NAS:VOR)
$ 19.14 -0.61 (-3.09%) Market Cap: 1.04 Bil Enterprise Value: 548.53 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 32/100

Vor Biopharma Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 13, 2023 / 05:20PM GMT
Release Date Price: $94.2 (+0.64%)
Matt Biegler
Oppenheimer & Co. Inc. - Analyst

Hey, good afternoon, everyone. Thanks for joining Oppenheimer's 33rd Annual Healthcare Conference. Super pumped to be with our next presenter. This is Vor Bio. We are joined by CEO, Dr. Robert Ang. Hey, Rob. We are going to do kind of an impromptu fireside. This was not prepared in any way. So if I do a terrible job, you can give me a rotten tomato on it. Anyways, Rob, thanks for joining again.

Questions & Answers

Matt Biegler
Oppenheimer & Co. Inc. - Analyst

You guys are trying to change the treatment paradigm. I guess, for those that aren't familiar, right, you just always start off with the 30,000 foot view. It's a really aspirational goal that you're trying to do. You're trying to change the treatment paradigm for blood cancers. Can you just kind of describe what that means just to maybe frame the conversation?

Robert Ang
Vor Biopharma Inc. - President and CEO

Sure, Matt. Thanks again for allowing us to participate. So Vor Bio is working to try

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot